Ardelyx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines.

CEO

Michael G. Raab

CEOMichael G. Raab

Employees

395

Employees395

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2007

Founded2007

Employees

395

Employees395

ARDX Key Statistics

Market cap

1.23B

Market cap1.23B

Price-Earnings ratio

-21.29

Price-Earnings ratio-21.29

Dividend yield

—

Dividend yield—

Average volume

3.53M

Average volume3.53M

High today

$5.18

High today$5.18

Low today

$4.93

Low today$4.93

Open price

$5.06

Open price$5.06

Volume

3.71M

Volume3.71M

52 Week high

$6.78

52 Week high$6.78

52 Week low

$3.21

52 Week low$3.21

ARDX News

Simply Wall St 4d

A Look at Ardelyx’s Valuation Following CFO Appointment and Strategic Leadership Shift

Ardelyx (ARDX) just named Sue Hohenleitner as its next Chief Financial Officer, tapping into her decades of experience at Johnson & Johnson. This leadership cha...

TipRanks 6d

Ardelyx Appoints New CFO Sue Hohenleitner

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 7d

Will Ardelyx’s New CFO Appointment Signal a Shift in Financial Strategy and Growth Priorities?

Ardelyx announced the upcoming appointment of Sue Hohenleitner as Chief Financial Officer, effective November 4, 2025, following the completion of its third qua...

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.